The 100 day mission - CX300 fits in beautifully15 Mar 2022 13:21
THE CASE FOR A 100 DAY MISSION
Imagine a scenario where COVID-19 had hit, but the world was ready. A scenario where:
A responsive diagnostics sector swung into action, producing accurate and rapid diagnostic tests at scale to detect new cases early, monitor contacts, and guide critical public health intervention.
The research and development had already been completed and prototype diagnostics and therapeutics only needed tweaking before they could be subjected, along with vaccines, to rapid assessment through an established international clinical trials network to quickly affirm their safety and efficacy.
Global manufacturing capacity was there and swiftly activated, ready to produce accurate diagnostics quickly and therapeutics and vaccines at scale to those who need them.
The World Health Organization (WHO), upon declaring a Public Health Emergency of International Concern (PHEIC), enacted agreed protocols setting out the ‘rules of the road’ for a pandemic, speeding up data sharing and regulatory approvals and triggering procurement pools for diagnostics, therapeutics and vaccines (DTVs).
There was sufficient financing available, and ready to draw down, to get DTVs to the poorest countries at the scale needed.
In this scenario, the world could have deployed safe and effective DTVs in May 2020, and hundreds of thousands of lives would have been saved, lockdowns would have been shortened, and trillions of dollars of lost economic output saved.
In the first 100 days from a pandemic threat being identified (defined by when WHO declares a PHEIC) we should aim for the following interventions to be available, safe, effective and affordable:
Accurate and approved rapid point of care Diagnostic tests;
https://www.gov.uk/government/publications/100-days-mission-to-respond-to-future-pandemic-threats
Sign In
Follow the stocks
